| Net income | |
| Expense (benefit) for deferred income taxes | |
| Depreciation and software amortization | |
| Amortization of intangible assets | |
| Change in valuation of contingent consideration | |
| Benefit related to embedded option | |
| Share-based compensation expense | |
| Provision for bad debts | |
| Other, net | |
| Trade accounts receivable | |
| Prepaid expenses and other assets | |
| Accounts payable and other liabilities | |
| Excess tax benefit related to share-based compensation | |
| Other | |
| Net cash provided by operating activities | |
| Purchase of property and equipment | -8.23M |
| Internally developed software costs | -4.85M |
| Cash paid for business acquisition, net of cash acquired | 0 |
| Other investing activities, net | |
| Net cash used in investing activities | |
| Proceeds from revolver | 31M |
| Payments on revolver | -13M |
| Payments under long-term obligations | -6.34M |
| Excess tax benefit related to share-based compensation | 0 |
| Common stock repurchases (Note 9) | -4.88M |
| Cash dividends paid (Note 9) | -6.77M |
| Debt issuance costs | 0 |
| Proceeds from issuance of common stock under share-based compensation plans | 47K |
| Net cash provided by (used in) financing activities | |
| Effect of exchange rate changes on cash | |
| DECREASE IN CASH AND CASH EQUIVALENTS | -10.32M |
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 27.62M |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | 17.3M |